Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine + CPAP for OAB in OSAS
NCT05250245Phase 4Completed
- Sponsor
- Van Yuzuncu Yil University
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in overactive bladder (OAB), sponsored by Van Yuzuncu Yil University. Started Jun 2020; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT05250245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05250245.